We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2127:TSEISTE Analysis

Data as of 2026-05-19 - not real-time

₩11,620.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Technical snapshot: ISTE trades at 11,620 KRW, comfortably above its 20‑day (9,738) and 50‑day (8,502) SMAs and also above the 200‑day SMA (9,329), indicating short‑term momentum. However, the RSI of 74.7 flags an overbought condition, and the MACD histogram remains positive (166) but may be losing steam as price nears the resistance level of 12,120. Volume is on an upward trend, supporting the recent price rise, yet the overall trend direction is listed as neutral. Volatility is high at 61.6% over the past 30 days, and a beta of 1.20 suggests the stock moves more aggressively than the market, amplifying risk.
Fundamental backdrop: Revenue growth is flat (0.4%) with thin gross margins (7.96%) and a steep operating loss of 31.4%, resulting in negative EBITDA and a free cash flow deficit of –2.46 bn KRW. The balance sheet is heavily leveraged (debt‑to‑equity 135%) and total debt (27.8 bn KRW) far exceeds cash holdings (12.5 bn KRW). A discounted cash‑flow model values the company at roughly 4,630 KRW, less than half the current market price, indicating significant overvaluation. The firm pays no dividend, and analyst coverage is absent, underscoring uncertainty about its turnaround prospects.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI in overbought territory
  • price approaching strong resistance
  • high leverage and negative cash flow

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • persistent operating losses
  • valuation gap between market price and DCF
  • increasing trading volume suggesting market interest

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • potential upside from semiconductor equipment demand
  • need for balance‑sheet restructuring
  • high beta and volatility increasing long‑run uncertainty

Key Metrics & Analysis

Financial Health

Revenue Growth0.40%
Profit Margin-14.06%
ROE-30.74%
ROA-6.38%
Debt/Equity135.35
Op. Cash Flow₩6.3B
Free Cash Flow₩-2460424704
Industry P/E29.5

Technical Analysis

TrendNeutral
RSI74.7
Support₩8,270.00
Resistance₩12,120.00
MA 20₩9,738.00
MA 50₩8,502.40
MA 200₩9,329.40
MACDBullish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair Value₩4,629.39
GradeOvervalued
TypeValue

Risk Assessment

Beta1.20
Volatility61.57%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.